Name | Title | Contact Details |
---|
Abeona Therapeutics is focused on developing and delivering gene therapy and plasma-based products for severe and life-threatening rare diseases. Abeona’s lead program is an adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome (MPS IIIA and IIIB) in collaboration with patient advocate groups, researchers and clinicians. Clinical trials for Sanfilippo types A and B are anticipated to begin in 2015.
HedgePath Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company that discovers, develops and plans to commercialize innovative therapeutics for patients with cancer. The Company may also explore acquiring or licensing innovative therapeutics addressing unmet needs and orphan indications beyond cancer. We are focused on the development of therapies for more than one type of cancer, with initial emphasis in the U.S. market, based upon repurposing the currently marketed antifungal drug itraconazole for new indications in oncology.
Addiction Prevention is a Washington, DC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Active Pharma is a Surrey, BC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
The New York Foundling Hospital is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. The New York Foundling Hospital is based in New York, NY. You can find more information on The New York Foundling Hospital at www.nyfoundling.org